 | • レポートコード：GIR-107A12449 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、マールブルグウイルス感染症のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。マールブルグウイルス感染症の種類別市場規模（エリトラン四ナトリウム、AR-12、ARD-5、AVI-7288、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・マールブルグウイルス感染症の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Arno Therapeutics Inc、BioCryst Pharmaceuticals Inc、Eisai Co Ltd、Emergent BioSolutions Inc、Fab'entech SA、Integrated BioTherapeutics Inc、Johnson & Johnson、NanoViricides Inc、Profectus BioSciences Inc、Rodos BioTarget GmbH、Sarepta Therapeutics Inc、Theravectys SA ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：エリトラン四ナトリウム、AR-12、ARD-5、AVI-7288、その他 ・用途別分析2016年-2026年：病院、クリニック、その他 ・マールブルグウイルス感染症の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・マールブルグウイルス感染症のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・マールブルグウイルス感染症のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・マールブルグウイルス感染症の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・マールブルグウイルス感染症の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Marburgvirus Infection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Marburgvirus Infection size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Marburgvirus Infection market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Marburgvirus Infection market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Eritoran Tetrasodium
AR-12
ARD-5
AVI-7288
Others
Market segment by Application, can be divided into
Hospital
Clinic
Others
Market segment by players, this report covers
Arno Therapeutics Inc
BioCryst Pharmaceuticals Inc
Eisai Co Ltd
Emergent BioSolutions Inc
Fab’entech SA
Integrated BioTherapeutics Inc
Johnson & Johnson
NanoViricides Inc
Profectus BioSciences Inc
Rodos BioTarget GmbH
Sarepta Therapeutics Inc
Theravectys SA
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Marburgvirus Infection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Marburgvirus Infection, with revenue, gross margin and global market share of Marburgvirus Infection from 2019 to 2021.
Chapter 3, the Marburgvirus Infection competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Marburgvirus Infection market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Marburgvirus Infection research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Marburgvirus Infection
1.2 Classification of Marburgvirus Infection by Type
1.2.1 Overview: Global Marburgvirus Infection Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Marburgvirus Infection Revenue Market Share by Type in 2020
1.2.3 Eritoran Tetrasodium
1.2.4 AR-12
1.2.5 ARD-5
1.2.6 AVI-7288
1.2.7 Others
1.3 Global Marburgvirus Infection Market by Application
1.3.1 Overview: Global Marburgvirus Infection Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Marburgvirus Infection Market Size & Forecast
1.5 Global Marburgvirus Infection Market Size and Forecast by Region
1.5.1 Global Marburgvirus Infection Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Marburgvirus Infection Market Size by Region, (2016-2021)
1.5.3 North America Marburgvirus Infection Market Size and Prospect (2016-2026)
1.5.4 Europe Marburgvirus Infection Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Marburgvirus Infection Market Size and Prospect (2016-2026)
1.5.6 South America Marburgvirus Infection Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Marburgvirus Infection Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Marburgvirus Infection Market Drivers
1.6.2 Marburgvirus Infection Market Restraints
1.6.3 Marburgvirus Infection Trends Analysis
2 Company Profiles
2.1 Arno Therapeutics Inc
2.1.1 Arno Therapeutics Inc Details
2.1.2 Arno Therapeutics Inc Major Business
2.1.3 Arno Therapeutics Inc Marburgvirus Infection Product and Solutions
2.1.4 Arno Therapeutics Inc Marburgvirus Infection Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Arno Therapeutics Inc Recent Developments and Future Plans
2.2 BioCryst Pharmaceuticals Inc
2.2.1 BioCryst Pharmaceuticals Inc Details
2.2.2 BioCryst Pharmaceuticals Inc Major Business
2.2.3 BioCryst Pharmaceuticals Inc Marburgvirus Infection Product and Solutions
2.2.4 BioCryst Pharmaceuticals Inc Marburgvirus Infection Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 BioCryst Pharmaceuticals Inc Recent Developments and Future Plans
2.3 Eisai Co Ltd
2.3.1 Eisai Co Ltd Details
2.3.2 Eisai Co Ltd Major Business
2.3.3 Eisai Co Ltd Marburgvirus Infection Product and Solutions
2.3.4 Eisai Co Ltd Marburgvirus Infection Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Eisai Co Ltd Recent Developments and Future Plans
2.4 Emergent BioSolutions Inc
2.4.1 Emergent BioSolutions Inc Details
2.4.2 Emergent BioSolutions Inc Major Business
2.4.3 Emergent BioSolutions Inc Marburgvirus Infection Product and Solutions
2.4.4 Emergent BioSolutions Inc Marburgvirus Infection Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Emergent BioSolutions Inc Recent Developments and Future Plans
2.5 Fab’entech SA
2.5.1 Fab’entech SA Details
2.5.2 Fab’entech SA Major Business
2.5.3 Fab’entech SA Marburgvirus Infection Product and Solutions
2.5.4 Fab’entech SA Marburgvirus Infection Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Fab’entech SA Recent Developments and Future Plans
2.6 Integrated BioTherapeutics Inc
2.6.1 Integrated BioTherapeutics Inc Details
2.6.2 Integrated BioTherapeutics Inc Major Business
2.6.3 Integrated BioTherapeutics Inc Marburgvirus Infection Product and Solutions
2.6.4 Integrated BioTherapeutics Inc Marburgvirus Infection Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Integrated BioTherapeutics Inc Recent Developments and Future Plans
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Marburgvirus Infection Product and Solutions
2.7.4 Johnson & Johnson Marburgvirus Infection Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Johnson & Johnson Recent Developments and Future Plans
2.8 NanoViricides Inc
2.8.1 NanoViricides Inc Details
2.8.2 NanoViricides Inc Major Business
2.8.3 NanoViricides Inc Marburgvirus Infection Product and Solutions
2.8.4 NanoViricides Inc Marburgvirus Infection Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 NanoViricides Inc Recent Developments and Future Plans
2.9 Profectus BioSciences Inc
2.9.1 Profectus BioSciences Inc Details
2.9.2 Profectus BioSciences Inc Major Business
2.9.3 Profectus BioSciences Inc Marburgvirus Infection Product and Solutions
2.9.4 Profectus BioSciences Inc Marburgvirus Infection Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Profectus BioSciences Inc Recent Developments and Future Plans
2.10 Rodos BioTarget GmbH
2.10.1 Rodos BioTarget GmbH Details
2.10.2 Rodos BioTarget GmbH Major Business
2.10.3 Rodos BioTarget GmbH Marburgvirus Infection Product and Solutions
2.10.4 Rodos BioTarget GmbH Marburgvirus Infection Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Rodos BioTarget GmbH Recent Developments and Future Plans
2.11 Sarepta Therapeutics Inc
2.11.1 Sarepta Therapeutics Inc Details
2.11.2 Sarepta Therapeutics Inc Major Business
2.11.3 Sarepta Therapeutics Inc Marburgvirus Infection Product and Solutions
2.11.4 Sarepta Therapeutics Inc Marburgvirus Infection Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Sarepta Therapeutics Inc Recent Developments and Future Plans
2.12 Theravectys SA
2.12.1 Theravectys SA Details
2.12.2 Theravectys SA Major Business
2.12.3 Theravectys SA Marburgvirus Infection Product and Solutions
2.12.4 Theravectys SA Marburgvirus Infection Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Theravectys SA Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Marburgvirus Infection Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Marburgvirus Infection Players Market Share
3.2.2 Top 10 Marburgvirus Infection Players Market Share
3.2.3 Market Competition Trend
3.3 Marburgvirus Infection Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Marburgvirus Infection Revenue and Market Share by Type (2016-2021)
4.2 Global Marburgvirus Infection Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Marburgvirus Infection Revenue Market Share by Application (2016-2021)
5.2 Marburgvirus Infection Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Marburgvirus Infection Revenue by Type (2016-2026)
6.2 North America Marburgvirus Infection Revenue by Application (2016-2026)
6.3 North America Marburgvirus Infection Market Size by Country
6.3.1 North America Marburgvirus Infection Revenue by Country (2016-2026)
6.3.2 United States Marburgvirus Infection Market Size and Forecast (2016-2026)
6.3.3 Canada Marburgvirus Infection Market Size and Forecast (2016-2026)
6.3.4 Mexico Marburgvirus Infection Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Marburgvirus Infection Revenue by Type (2016-2026)
7.2 Europe Marburgvirus Infection Revenue by Application (2016-2026)
7.3 Europe Marburgvirus Infection Market Size by Country
7.3.1 Europe Marburgvirus Infection Revenue by Country (2016-2026)
7.3.2 Germany Marburgvirus Infection Market Size and Forecast (2016-2026)
7.3.3 France Marburgvirus Infection Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Marburgvirus Infection Market Size and Forecast (2016-2026)
7.3.5 Russia Marburgvirus Infection Market Size and Forecast (2016-2026)
7.3.6 Italy Marburgvirus Infection Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Marburgvirus Infection Revenue by Type (2016-2026)
8.2 Asia-Pacific Marburgvirus Infection Revenue by Application (2016-2026)
8.3 Asia-Pacific Marburgvirus Infection Market Size by Region
8.3.1 Asia-Pacific Marburgvirus Infection Revenue by Region (2016-2026)
8.3.2 China Marburgvirus Infection Market Size and Forecast (2016-2026)
8.3.3 Japan Marburgvirus Infection Market Size and Forecast (2016-2026)
8.3.4 South Korea Marburgvirus Infection Market Size and Forecast (2016-2026)
8.3.5 India Marburgvirus Infection Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Marburgvirus Infection Market Size and Forecast (2016-2026)
8.3.7 Australia Marburgvirus Infection Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Marburgvirus Infection Revenue by Type (2016-2026)
9.2 South America Marburgvirus Infection Revenue by Application (2016-2026)
9.3 South America Marburgvirus Infection Market Size by Country
9.3.1 South America Marburgvirus Infection Revenue by Country (2016-2026)
9.3.2 Brazil Marburgvirus Infection Market Size and Forecast (2016-2026)
9.3.3 Argentina Marburgvirus Infection Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Marburgvirus Infection Revenue by Type (2016-2026)
10.2 Middle East & Africa Marburgvirus Infection Revenue by Application (2016-2026)
10.3 Middle East & Africa Marburgvirus Infection Market Size by Country
10.3.1 Middle East & Africa Marburgvirus Infection Revenue by Country (2016-2026)
10.3.2 Turkey Marburgvirus Infection Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Marburgvirus Infection Market Size and Forecast (2016-2026)
10.3.4 UAE Marburgvirus Infection Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Marburgvirus Infection Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Marburgvirus Infection Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Marburgvirus Infection Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Marburgvirus Infection Revenue (USD Million) by Region (2016-2021)
Table 5. Global Marburgvirus Infection Revenue Market Share by Region (2021-2026)
Table 6. Arno Therapeutics Inc Corporate Information, Head Office, and Major Competitors
Table 7. Arno Therapeutics Inc Major Business
Table 8. Arno Therapeutics Inc Marburgvirus Infection Product and Solutions
Table 9. Arno Therapeutics Inc Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. BioCryst Pharmaceuticals Inc Corporate Information, Head Office, and Major Competitors
Table 11. BioCryst Pharmaceuticals Inc Major Business
Table 12. BioCryst Pharmaceuticals Inc Marburgvirus Infection Product and Solutions
Table 13. BioCryst Pharmaceuticals Inc Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Eisai Co Ltd Corporate Information, Head Office, and Major Competitors
Table 15. Eisai Co Ltd Major Business
Table 16. Eisai Co Ltd Marburgvirus Infection Product and Solutions
Table 17. Eisai Co Ltd Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Emergent BioSolutions Inc Corporate Information, Head Office, and Major Competitors
Table 19. Emergent BioSolutions Inc Major Business
Table 20. Emergent BioSolutions Inc Marburgvirus Infection Product and Solutions
Table 21. Emergent BioSolutions Inc Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Fab'entech SA Corporate Information, Head Office, and Major Competitors
Table 23. Fab'entech SA Major Business
Table 24. Fab'entech SA Marburgvirus Infection Product and Solutions
Table 25. Fab'entech SA Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Integrated BioTherapeutics Inc Corporate Information, Head Office, and Major Competitors
Table 27. Integrated BioTherapeutics Inc Major Business
Table 28. Integrated BioTherapeutics Inc Marburgvirus Infection Product and Solutions
Table 29. Integrated BioTherapeutics Inc Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 31. Johnson & Johnson Major Business
Table 32. Johnson & Johnson Marburgvirus Infection Product and Solutions
Table 33. Johnson & Johnson Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. NanoViricides Inc Corporate Information, Head Office, and Major Competitors
Table 35. NanoViricides Inc Major Business
Table 36. NanoViricides Inc Marburgvirus Infection Product and Solutions
Table 37. NanoViricides Inc Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Profectus BioSciences Inc Corporate Information, Head Office, and Major Competitors
Table 39. Profectus BioSciences Inc Major Business
Table 40. Profectus BioSciences Inc Marburgvirus Infection Product and Solutions
Table 41. Profectus BioSciences Inc Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Rodos BioTarget GmbH Corporate Information, Head Office, and Major Competitors
Table 43. Rodos BioTarget GmbH Major Business
Table 44. Rodos BioTarget GmbH Marburgvirus Infection Product and Solutions
Table 45. Rodos BioTarget GmbH Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Sarepta Therapeutics Inc Corporate Information, Head Office, and Major Competitors
Table 47. Sarepta Therapeutics Inc Major Business
Table 48. Sarepta Therapeutics Inc Marburgvirus Infection Product and Solutions
Table 49. Sarepta Therapeutics Inc Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Theravectys SA Corporate Information, Head Office, and Major Competitors
Table 51. Theravectys SA Major Business
Table 52. Theravectys SA Marburgvirus Infection Product and Solutions
Table 53. Theravectys SA Marburgvirus Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Marburgvirus Infection Revenue (USD Million) by Players (2019-2021)
Table 55. Global Marburgvirus Infection Revenue Share by Players (2019-2021)
Table 56. Breakdown of Marburgvirus Infection by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Marburgvirus Infection Players Head Office, Products and Services Provided
Table 58. Marburgvirus Infection Mergers & Acquisitions in the Past Five Years
Table 59. Marburgvirus Infection New Entrants and Expansion Plans
Table 60. Global Marburgvirus Infection Revenue (USD Million) by Type (2016-2021)
Table 61. Global Marburgvirus Infection Revenue Share by Type (2016-2021)
Table 62. Global Marburgvirus Infection Revenue Forecast by Type (2021-2026)
Table 63. Global Marburgvirus Infection Revenue by Application (2016-2021)
Table 64. Global Marburgvirus Infection Revenue Forecast by Application (2021-2026)
Table 65. North America Marburgvirus Infection Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Marburgvirus Infection Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Marburgvirus Infection Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Marburgvirus Infection Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Marburgvirus Infection Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Marburgvirus Infection Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Marburgvirus Infection Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Marburgvirus Infection Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Marburgvirus Infection Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Marburgvirus Infection Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Marburgvirus Infection Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Marburgvirus Infection Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Marburgvirus Infection Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Marburgvirus Infection Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Marburgvirus Infection Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Marburgvirus Infection Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Marburgvirus Infection Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Marburgvirus Infection Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Marburgvirus Infection Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Marburgvirus Infection Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Marburgvirus Infection Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Marburgvirus Infection Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Marburgvirus Infection Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Marburgvirus Infection Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Marburgvirus Infection Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Marburgvirus Infection Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Marburgvirus Infection Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Marburgvirus Infection Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Marburgvirus Infection Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Marburgvirus Infection Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Marburgvirus Infection Picture
Figure 2. Global Marburgvirus Infection Revenue Market Share by Type in 2020
Figure 3. Eritoran Tetrasodium
Figure 4. AR-12
Figure 5. ARD-5
Figure 6. AVI-7288
Figure 7. Others
Figure 8. Marburgvirus Infection Revenue Market Share by Application in 2020
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Others Picture
Figure 12. Global Marburgvirus Infection Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Marburgvirus Infection Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Marburgvirus Infection Revenue Market Share by Region (2016-2026)
Figure 15. Global Marburgvirus Infection Revenue Market Share by Region in 2020
Figure 16. North America Marburgvirus Infection Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Marburgvirus Infection Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Marburgvirus Infection Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Marburgvirus Infection Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Marburgvirus Infection Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Marburgvirus Infection Market Drivers
Figure 22. Marburgvirus Infection Market Restraints
Figure 23. Marburgvirus Infection Market Trends
Figure 24. Arno Therapeutics Inc Recent Developments and Future Plans
Figure 25. BioCryst Pharmaceuticals Inc Recent Developments and Future Plans
Figure 26. Eisai Co Ltd Recent Developments and Future Plans
Figure 27. Emergent BioSolutions Inc Recent Developments and Future Plans
Figure 28. Fab'entech SA Recent Developments and Future Plans
Figure 29. Integrated BioTherapeutics Inc Recent Developments and Future Plans
Figure 30. Johnson & Johnson Recent Developments and Future Plans
Figure 31. NanoViricides Inc Recent Developments and Future Plans
Figure 32. Profectus BioSciences Inc Recent Developments and Future Plans
Figure 33. Rodos BioTarget GmbH Recent Developments and Future Plans
Figure 34. Sarepta Therapeutics Inc Recent Developments and Future Plans
Figure 35. Theravectys SA Recent Developments and Future Plans
Figure 36. Global Marburgvirus Infection Revenue Share by Players in 2020
Figure 37. Marburgvirus Infection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Marburgvirus Infection Revenue Market Share in 2020
Figure 39. Global Top 10 Players Marburgvirus Infection Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Marburgvirus Infection Revenue Share by Type in 2020
Figure 42. Global Marburgvirus Infection Market Share Forecast by Type (2021-2026)
Figure 43. Global Marburgvirus Infection Revenue Share by Application in 2020
Figure 44. Global Marburgvirus Infection Market Share Forecast by Application (2021-2026)
Figure 45. North America Marburgvirus Infection Sales Market Share by Type (2016-2026)
Figure 46. North America Marburgvirus Infection Sales Market Share by Application (2016-2026)
Figure 47. North America Marburgvirus Infection Revenue Market Share by Country (2016-2026)
Figure 48. United States Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Marburgvirus Infection Sales Market Share by Type (2016-2026)
Figure 52. Europe Marburgvirus Infection Sales Market Share by Application (2016-2026)
Figure 53. Europe Marburgvirus Infection Revenue Market Share by Country (2016-2026)
Figure 54. Germany Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Marburgvirus Infection Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Marburgvirus Infection Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Marburgvirus Infection Revenue Market Share by Region (2016-2026)
Figure 62. China Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Marburgvirus Infection Sales Market Share by Type (2016-2026)
Figure 69. South America Marburgvirus Infection Sales Market Share by Application (2016-2026)
Figure 70. South America Marburgvirus Infection Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Marburgvirus Infection Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Marburgvirus Infection Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Marburgvirus Infection Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Marburgvirus Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界の腸内細菌科感染症薬市場 2021：企業別、地域別、種類・用途別 The Enterobacteriaceae Infection Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…- 世界のグラム陽性菌感染症治療薬市場 2021：企業別、地域別、種類・用途別 The Gram-positive Bacterial Infection Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界の感染管理歯科用消耗品市場 2021：企業別、地域別、種類・用途別 The Infection Control Dental Consumables market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 感染制御製品市場：世界及び中国市場分析・予測（～2024年） Infection Control Product Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Infection Control Product industry with a focus on the Chinese market. The report provides key statistics on the market status of the Infection Control …
- 世界のサイトメガロウイルス（HHV-5）感染症治療薬市場 2021：企業別、地域別、種類・用途別 The Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…